Formamide compounds as therapeutic agents
US6191150A · kind A · utility
3Cited by
4References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 1999 |
| Grant date | Feb 20, 2001 |
| Priority date | — |
| Expiry date | Aug 25, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D277/46
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A family of compounds having the general structural formula ##STR1## where W is a reverse hydroxamic acid group, and R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are as described in the specification, or a pharmaceutically acceptable salt, solvate, biohydrolyzable ester, biohydrolyzable amide, affinity reagent, or prodrug thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.